These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34560683)

  • 81. Body Cavity-Based Lymphoma in a Country with Low Human Immunodeficiency Virus Prevalence: A Series of 17 Cases from the Consortium for Improving Survival of Lymphoma.
    Shin J; Ko YH; Oh SY; Yoon DH; Lee JO; Kim JS; Park Y; Shin HJ; Kim SJ; Won JH; Yoon SS; Kim WS; Koh Y;
    Cancer Res Treat; 2019 Oct; 51(4):1302-1312. PubMed ID: 30764603
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study.
    Hu LY; Xu XL; Rao HL; Chen J; Lai RC; Huang HQ; Jiang WQ; Lin TY; Xia ZJ; Cai QQ
    Chin J Cancer; 2017 Dec; 36(1):94. PubMed ID: 29246182
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand.
    Pongpruttipan T; Kummalue T; Bedavanija A; Khuhapinant A; Ohshima K; Arakawa F; Niino D; Sukpanichnant S
    Diagn Pathol; 2011 Aug; 6():79. PubMed ID: 21867533
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis.
    Kim WY; Jung HY; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK
    Virchows Arch; 2016 Nov; 469(5):581-590. PubMed ID: 27595782
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for Immunotherapy.
    Yanik EL; Kaunitz GJ; Cottrell TR; Succaria F; McMiller TL; Ascierto ML; Esandrio J; Xu H; Ogurtsova A; Cornish T; Lipson EJ; Topalian SL; Engels EA; Taube JM
    JAMA Oncol; 2017 Jul; 3(7):974-978. PubMed ID: 28334399
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study.
    Ha SY; Sung J; Ju H; Karube K; Kim SJ; Kim WS; Seto M; Ko YH
    Pathol Res Pract; 2013 Jul; 209(7):448-54. PubMed ID: 23735590
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prognostic Value of Programmed Cell Death-Ligand 1 Expression in Tumor-Infiltrating Lymphocytes and Viral Load in Peripheral Blood Mononuclear Cells for Epstein-Barr Virus-Positive Nasopharyngeal Carcinoma.
    Hu B; Sun M; Wang Z; Zheng Y; Cai W; Shi HH; Zhuang Y; Lin Q
    Clin Chem; 2020 Sep; 66(9):1219-1227. PubMed ID: 32870999
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions.
    Komanduri KV; Luce JA; McGrath MS; Herndier BG; Ng VL
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Nov; 13(3):215-26. PubMed ID: 8898666
    [TBL] [Abstract][Full Text] [Related]  

  • 89. EBV-positive diffuse large B-cell lymphoma features PD-L1 protein but not mRNA overexpression.
    Xue T; Wang WG; Zhou XY; Li XQ
    Pathology; 2018 Dec; 50(7):725-729. PubMed ID: 30389217
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women.
    Said JW; Tasaka T; Takeuchi S; Asou H; de Vos S; Cesarman E; Knowles DM; Koeffler HP
    Blood; 1996 Oct; 88(8):3124-8. PubMed ID: 8874212
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significance.
    Fisher KE; Ferguson LS; Coffey AM; Merritt BY; Curry JL; Marcogliese AN; Major AM; Kamdar KY; Lopez-Terrada DH; Curry CV
    Haematologica; 2022 Aug; 107(8):1880-1890. PubMed ID: 35081690
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Genotypic and phenotypic alterations in Epstein-Barr virus-associated lymphoma.
    Ohshima K; Suzumiya J; Kanda M; Haraoka S; Kawasaki C; Shimazaki K; Kikuchi M
    Histopathology; 1999 Dec; 35(6):539-50. PubMed ID: 10583578
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus.
    Kanavaros P; Lescs MC; Brière J; Divine M; Galateau F; Joab I; Bosq J; Farcet JP; Reyes F; Gaulard P
    Blood; 1993 May; 81(10):2688-95. PubMed ID: 8387835
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Analysis of Immunological Characteristics and Genomic Alterations in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Based on PD-L1 Expression.
    Xu SM; Shi CJ; Xia RH; Wang LZ; Tian Z; Ye WM; Liu L; Liu SL; Zhang CY; Hu YH; Zhou R; Han Y; Wang Y; Zhang ZY; Li J
    Front Immunol; 2021; 12():798424. PubMed ID: 35145511
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Primary effusion lymphoma associated with Human Herpes Virus-8 and Epstein Barr virus in an HIV-infected woman from Kampala, Uganda: a case report.
    Tumwine LK; Lalitha R; Agostinelli C; Luzige S; Orem J; Piccaluga PP; Osuwat LO; Pileri SA
    J Med Case Rep; 2011 Feb; 5():60. PubMed ID: 21320326
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells.
    Sakakibara A; Kohno K; Eladl AE; Klaisuwan T; Ishikawa E; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Kato S; Asano N; Nakamura S; Satou A
    Histopathology; 2018 Jun; 72(7):1156-1163. PubMed ID: 29380399
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation.
    Matolcsy A; Nádor RG; Cesarman E; Knowles DM
    Am J Pathol; 1998 Nov; 153(5):1609-14. PubMed ID: 9811353
    [TBL] [Abstract][Full Text] [Related]  

  • 98. EBV Positive Diffuse Large B Cell Lymphoma with Negative Pan-B Cell Markers, Case Report, and Literature Review.
    Shold J; Jukic L; Farrell D; Cui W; Zhang D
    Case Rep Hematol; 2024; 2024():4803071. PubMed ID: 39055348
    [TBL] [Abstract][Full Text] [Related]  

  • 99. 'Discovering' primary effusion lymphoma in Malawi.
    Dhungel BM; Montgomery ND; Painschab MS; Mulenga M; Tomoka T; Kaimila B; Zuze T; Kasonkanji E; Kampani C; Chimzimu F; Randall C; Krysiak R; Seguin R; Fedoriw Y; Gopal S
    AIDS; 2018 Sep; 32(15):2264-2266. PubMed ID: 30212407
    [No Abstract]   [Full Text] [Related]  

  • 100. Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up.
    Vega F; Amador C; Chadburn A; Hsi ED; Slack G; Medeiros LJ; Feldman AL
    Mod Pathol; 2022 Mar; 35(3):306-318. PubMed ID: 34584212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.